126
Participants
Start Date
December 31, 2012
Primary Completion Date
September 30, 2016
Study Completion Date
September 30, 2016
galeterone
Mount Sinai, New York
Roswell Park Center Institute, Buffalo
University of Maryland, Baltimore
Sidney Kimmel Johns Hopkins, Baltimore
AAHS Research Institute, Annapolis
Carolina Clinical Trials, Concord
Carolina Urologic Research Center, Myrtle Beach
Greenville Hospital System University Medical Center, Greenville
Raton Regional Hospital, Lynn Cancer Institute, Boca Raton
Karmanos Cancer Institute, Detroit
Urology Cancer Center and GU Research Network, Omaha
Tulane Cancer Center, New Orleans
Urology Clinics of North Texas, Dallas
San Bernardino Urological Associates, San Bernardino
University of Washington/Seattle Cancer Care Alliance, Seattle
UCLA David Geffen School of Medicine, Los Angeles
Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston
Beth Israel Deaconess Medical Center, Boston
Coastal Urology Associates, Brick
Premier Urology Associates, LLC, Lawrenceville
BC Cancer Agency, Vancouver
Sunnybrook Health Sciences Centre, Toronto
Lead Sponsor
LTN PHARMACEUTICALS, INC.
INDUSTRY